Bedaquiline labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 37: | Line 37: | ||
{| | {| | ||
|- | |- | ||
| [[File:Bedaquiline06. | | [[File:Bedaquiline06.jpg|700px|thumb]] | ||
|- | |- | ||
|} | |} | ||
Revision as of 22:11, 23 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
This Medication Guide has been approved by the U.S. Food and Drug Administration
Issued: October 2013
PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Label
NDC 59676-701-01
Sirturo™ (bedaquiline) tablets
100 mg
Dispense Medication Guide to each patient
Attention Pharmacist: Dispense in original container. Tablets dispensed outside the original container should be stored in a tight light-resistant container with an expiration date not to exceed 3 months. Store at 25°C (77°F); Excursions permitted to 15°C-30°C (59°F - 86°F).[See USP Controlled Room Temperature].
188 Tablets
Rx only
Janssen a
 |
References
- ↑ "SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP]". Retrieved 23 December 2013.
Adapted from the FDA Package Insert.